Table 1.

The resorcinol scaffold HSP90 inhibitors used in this study have two types of scaffolds, triazolones (A) and pyrazoles (B), and vary in the substitutions R¹ and R². The compounds (cmpd) are sorted first according to their known and expected conformational effect on HSP90 and then with increasing residence time (listed in Table S3).